This document provides tips and instructions for using a PowerPoint presentation on Helicobacter pylori. Some key points:
- Blank slides are included to allow adding notes and engaging students by asking questions. The presentation is meant to be an active learning session conducted over multiple revisions.
- Topics covered include the microbiology of H. pylori, its role in diseases like peptic ulcers and gastric cancer, pathogenesis, clinical diagnosis using invasive and noninvasive tests, and treatment using antibiotic-based triple therapy.
- Futuristic areas discussed are preventive vaccination, the potential role of probiotics and gut microbiome, and research exploring both harmful and protective effects of H. pylori colonization
Helicobacter pylori is a bacteria that causes peptic ulcers and is linked to gastric cancer. There are invasive and non-invasive tests to diagnose H. pylori infection. Invasive tests include histology, culture, and rapid urease test, while non-invasive options are urea breath test, stool antigen test, and serology. Molecular techniques like PCR are also used and can identify specific genes or antibiotic resistance. The accuracy of diagnostic tests may be affected in cases of bleeding or partial gastrectomy. Post-treatment tests like urea breath test are recommended to confirm eradication success.
This document provides an overview of Helicobacter pylori infections. It discusses that H. pylori is the most common bacterial infection worldwide, affecting 70-90% of populations in developing countries. While most infections are asymptomatic, H. pylori can cause peptic ulcer disease in 10% of individuals and gastric cancer in 1%. The document outlines the microbiology of H. pylori, describing it as a gram-negative, microaerophilic spiral bacterium. It also discusses the pathogenesis of H. pylori infections and indications for testing. Treatment guidelines and various testing methods like invasive biopsy-based testing and non-invasive breath and stool antigen tests are also summarized.
Helicobacter pylori is the most common chronic bacterial infection worldwide. It colonizes the stomach and can cause gastric and duodenal ulcers or increase the risk of stomach cancer. Treatment usually involves a combination of antibiotics and proton pump inhibitors over 10-14 days, with success rates around 70-90% depending on the regimen. Factors like antibiotic resistance in the region affect treatment outcomes. Eradication is important to prevent future complications and is confirmed after treatment via a urea breath test or stool antigen test.
This document summarizes acute and chronic gastritis. Acute gastritis is caused by factors like NSAID use, alcohol, smoking, infections, and stress. It involves neutrophil infiltration and can cause erosions and ulceration. Chronic gastritis is defined by long-term inflammation leading to atrophy and intestinal metaplasia. Helicobacter pylori infection is a major cause and results in urease production and cytotoxins that drive chronic inflammation. Autoimmune mechanisms can also lead to chronic gastritis, seen as lymphocytes and plasma cells in the lamina propria and intestinal metaplasia.
Helicobacter pylori and Peptic Ulcer diseaseDiaa Srahin
Case Study
Clinical Case Summary
History
Helicobacter pylori
Biochemical characteristics
Transmission
Epidemiology
Global incidence of H. pylori infection
risk factors for acquisition of H.pylori
Immune responses
Pathogenesis
Helicobacter pylori Virulence Factors
Clinical Presentation
Complications
Peptic Ulcer
Diagnosis
Treatment
Prevention
This document discusses Helicobacter pylori infection. It begins with a summary of the discovery of H. pylori, including Giulio Bizzozero's initial description in 1892 and Robin Warren and Barry Marshall's cultivation of H. pylori in 1982. It then covers the epidemiology of H. pylori infection, indications for treatment, methods for diagnosing infection, treatments for infection, and the role of H. pylori eradication in preventing gastric cancer. Key points include that over 50% of the world's population is infected with H. pylori and treatment aims to cure ulcers and reduce cancer risk. Diagnosis involves non-invasive tests like serology or breath tests
Helicobacter pylori is a bacteria that causes peptic ulcers and is linked to gastric cancer. There are invasive and non-invasive tests to diagnose H. pylori infection. Invasive tests include histology, culture, and rapid urease test, while non-invasive options are urea breath test, stool antigen test, and serology. Molecular techniques like PCR are also used and can identify specific genes or antibiotic resistance. The accuracy of diagnostic tests may be affected in cases of bleeding or partial gastrectomy. Post-treatment tests like urea breath test are recommended to confirm eradication success.
This document provides an overview of Helicobacter pylori infections. It discusses that H. pylori is the most common bacterial infection worldwide, affecting 70-90% of populations in developing countries. While most infections are asymptomatic, H. pylori can cause peptic ulcer disease in 10% of individuals and gastric cancer in 1%. The document outlines the microbiology of H. pylori, describing it as a gram-negative, microaerophilic spiral bacterium. It also discusses the pathogenesis of H. pylori infections and indications for testing. Treatment guidelines and various testing methods like invasive biopsy-based testing and non-invasive breath and stool antigen tests are also summarized.
Helicobacter pylori is the most common chronic bacterial infection worldwide. It colonizes the stomach and can cause gastric and duodenal ulcers or increase the risk of stomach cancer. Treatment usually involves a combination of antibiotics and proton pump inhibitors over 10-14 days, with success rates around 70-90% depending on the regimen. Factors like antibiotic resistance in the region affect treatment outcomes. Eradication is important to prevent future complications and is confirmed after treatment via a urea breath test or stool antigen test.
This document summarizes acute and chronic gastritis. Acute gastritis is caused by factors like NSAID use, alcohol, smoking, infections, and stress. It involves neutrophil infiltration and can cause erosions and ulceration. Chronic gastritis is defined by long-term inflammation leading to atrophy and intestinal metaplasia. Helicobacter pylori infection is a major cause and results in urease production and cytotoxins that drive chronic inflammation. Autoimmune mechanisms can also lead to chronic gastritis, seen as lymphocytes and plasma cells in the lamina propria and intestinal metaplasia.
Helicobacter pylori and Peptic Ulcer diseaseDiaa Srahin
Case Study
Clinical Case Summary
History
Helicobacter pylori
Biochemical characteristics
Transmission
Epidemiology
Global incidence of H. pylori infection
risk factors for acquisition of H.pylori
Immune responses
Pathogenesis
Helicobacter pylori Virulence Factors
Clinical Presentation
Complications
Peptic Ulcer
Diagnosis
Treatment
Prevention
This document discusses Helicobacter pylori infection. It begins with a summary of the discovery of H. pylori, including Giulio Bizzozero's initial description in 1892 and Robin Warren and Barry Marshall's cultivation of H. pylori in 1982. It then covers the epidemiology of H. pylori infection, indications for treatment, methods for diagnosing infection, treatments for infection, and the role of H. pylori eradication in preventing gastric cancer. Key points include that over 50% of the world's population is infected with H. pylori and treatment aims to cure ulcers and reduce cancer risk. Diagnosis involves non-invasive tests like serology or breath tests
Helicobacter pylori is a spiral-shaped bacteria that lives in the stomach. It was originally considered that bacteria could not survive in the acidic stomach. Marshall and Warren first cultured H. pylori from human stomachs and showed it was associated with gastric inflammation. H. pylori infection can cause dyspepsia, peptic ulcers, gastric cancer, and other diseases. Testing and treating H. pylori infections can help prevent future illness.
The gallbladder is a hollow organ located beneath the liver that stores and concentrates bile. Cholecystitis is inflammation of the gallbladder, usually caused by gallstones blocking the cystic duct. Symptoms include pain in the upper right abdomen and fever. Ultrasound is often used to diagnose cholecystitis by detecting gallstones or thickening of the gallbladder wall. Treatment typically involves surgical removal of the gallbladder via laparoscopy.
Chronic hepatitis is defined as ongoing liver inflammation lasting over 6 months. It is commonly caused by hepatitis B, C, or a combination. Clinical features include fatigue, loss of appetite, jaundice, and elevated liver enzymes. On microscopy, chronic hepatitis shows piecemeal necrosis around the portal tract, interface hepatitis between liver lobes, and bridging fibrosis linking different areas. The activity of chronic hepatitis is assessed based on necrosis, inflammation, and fibrosis levels, and used to classify it as persistent, lobular, or active hepatitis. Carriers have no symptoms but can transmit hepatitis viruses through detectable surface antigens in their blood.
Helicobacter pylori is a spiral-shaped bacterium that can cause peptic ulcer disease and is associated with gastric cancer. It colonizes the stomach and causes a chronic inflammatory response. Several bacterial virulence factors like the cag pathogenicity island, vacuolating cytotoxin, and urease contribute to pathogenesis. H. pylori infection typically results in chronic gastritis and in some cases can lead to more severe outcomes like peptic ulcers, gastric atrophy, intestinal metaplasia, and cancer. Diagnosis involves endoscopy with biopsy to detect the bacteria through histology or other tests. Treatment aims to eradicate the infection through antibiotic therapy combined with proton pump inhibitors.
To know basic etiology of this disease and difference between duodenal ulcer and peptic ulcer as well as how we can approach if children having peptic ulcer disease. By conservative and surgical means
Laboratory diagnosis of H. Pylori infection, Ola ElgaddarOla Elgaddar
A short presentation for the different laboratory techniques used in diagnosing Helicobacter Pylori infection. A special focus is given for the diagnostic performance of every test.
This document provides information about Helicobacter pylori (H. pylori), including how it is transmitted, symptoms it causes, specimens used to test for it, and methods for diagnosing and confirming infection. H. pylori is a bacteria that infects the stomach and is associated with gastric ulcers and cancer. It is transmitted orally-orally or orally-fecal. Common symptoms include abdominal pain and weight loss. Diagnosis can be made through serology tests of whole blood, serum, stool or breath samples, or biopsy during endoscopy. Serology tests detect antibodies but cannot confirm active infection. Stool and breath tests can diagnose active infection and confirm cure. Biopsy during endoscopy
This document discusses Zollinger-Ellison syndrome, which is characterized by severe peptic ulcers caused by excessive stomach acid production due to a non-beta cell tumor known as a gastrinoma. It describes the pathophysiology, tumor distribution, clinical manifestations, diagnosis, and treatment of the condition. The gastrinoma secretes gastrin which stimulates acid secretion, potentially reaching the small intestine and inactivating pancreatic enzymes. Diagnosis involves biochemical tests and imaging to locate the tumor. Treatment options include proton pump inhibitors, somatostatin analogues, and surgery to cure the condition.
Inflammatory Bowel Disease (IBD) refers to two conditions: Crohn's disease and ulcerative colitis. Crohn's disease causes chronic inflammation of the gastrointestinal tract that can affect any location from mouth to anus in a discontinuous pattern. Ulcerative colitis causes non-granulomatous inflammation of the colon and rectum in a continuous pattern beginning in the rectum. The causes of IBD are not fully known but involve an immune reaction to environmental triggers in genetically predisposed individuals. Symptoms vary depending on the location and severity of inflammation. Management involves non-pharmacological approaches as well as medications to reduce inflammation like aminosalicates, corticosteroids, immunosuppress
Chronic gastritis is a chronic inflammation of the gastric mucosa that commonly results from infection by Helicobacter pylori in 90% of cases. Other causes include NSAID use, smoking, stress, and ischemia. H. pylori infection leads to increased acid secretion and damage to the gastric epithelium. Chronic gastritis is classified based on location and cause, and is usually asymptomatic, though pain, dyspepsia, and fatigue may occur. Diagnosis involves endoscopy, biopsy, and urease testing. Treatment focuses on H. pylori eradication therapy using antibiotic combinations for 10-14 days along with diet and lifestyle modifications. Complications include ulcers, gastric cancer, and
Peptic ulcer disease is caused by gastric or duodenal ulcers that form lesions in the stomach or duodenal mucosa. Risk factors include H. pylori infection, smoking, NSAID use, and genetic factors. Symptoms include epigastric pain relieved by food and antacids. Treatment aims to relieve pain, eradicate H. pylori infection, heal ulcers, and prevent recurrence through lifestyle changes and medication like PPIs or H2 blockers. Surgery was more common historically but is now rare due to H. pylori treatments, though it may be used for complications like perforation.
Chronic gastritis is long-term inflammation of the stomach lining that can be caused by factors like H. pylori infection, medications, alcohol, or diet. It is classified based on etiology (cause), morphology (appearance), and location in the stomach. The OLGA staging system scores and stages gastritis severity based on the degree of atrophy in the antrum and corpus as seen histologically. Treatment involves eliminating the cause, such as treating an H. pylori infection, and managing symptoms.
This document provides an overview of irritable bowel syndrome (IBS), including its definition, prevalence, demographics, pathophysiology, clinical features, diagnosis, differential diagnosis, severity assessment, management, and prognosis. Some key points are:
- IBS is a functional bowel disorder characterized by abdominal pain associated with changes in bowel habits. It predominantly affects those aged 15-65 and is more common in women.
- The pathophysiology involves altered gut motility, visceral hypersensitivity, abnormal gas handling, low-grade inflammation, food sensitivities, abnormal gut microbiota, and central nervous system dysregulation.
- Diagnosis is based on symptoms meeting certain criteria and exclusion of organic diseases. Management focuses on
Peptic ulcer disease is caused by Helicobacter pylori (Hp) infection and nonsteroidal anti-inflammatory drug (NSAID) use. Definitive diagnosis is by endoscopy, which can detect ulcers and test for Hp. Common complications are bleeding, perforation, and pyloric obstruction. Treatment involves eradicating Hp, relieving symptoms with anti-ulcer drugs, and preventing recurrence with long-term proton pump inhibitor use.
This document discusses gastroesophageal reflux disease (GERD). It begins by defining GERD as a condition caused by stomach contents refluxing into the esophagus and causing troublesome symptoms or complications. It then discusses the pathophysiology of GERD, noting that the lower esophageal sphincter normally acts as a barrier but can become disrupted, allowing acid to reflux from the stomach into the esophagus. The document outlines the clinical manifestations of GERD including heartburn, regurgitation, and extraesophageal symptoms. It also discusses diagnostic evaluations for GERD including endoscopy, pH monitoring, and manometry. The document concludes by covering treatment options for GERD including lifestyle modifications
The document discusses biliary dyskinesia, a disorder where the gallbladder does not contract and empty properly, causing digestive issues. It describes the anatomy and role of the biliary system, signs and symptoms of biliary dyskinesia including abdominal pain and nausea, potential causes, diagnostic tests and treatments including diet changes and medication. Nutritional guidelines recommend a low-fat diet, fiber, staying hydrated, supplements, weight management and probiotics to support gallbladder function and digestion.
This document provides an overview of amoebiasis (Entamoeba histolytica infection). It discusses the definition, life cycle, epidemiology, pathogenesis, clinical manifestations, diagnosis and treatment of intestinal amoebiasis as well as extra-intestinal infections such as amoebic liver abscess. Key points include that 90% of E. histolytica infections are asymptomatic but 10% can cause intestinal or extraintestinal disease ranging from dysentery to liver abscesses. Diagnosis involves microscopy of stool, biopsy or abscess aspirate samples. Treatment depends on the clinical presentation and involves metronidazole and other drugs.
Helicobacter pylori associated Peptic ulcer diseaseS M Ali Hasan
Helicobacter pylori is a common cause of peptic ulcer disease. It infects about half of the global population and transmission occurs through person-to-person contact or from infected instruments. Only 10-15% of infected individuals develop ulcers or other diseases. In Bangladesh, H. pylori infection rates are very high, ranging from 67-92% in studies. Treatment involves antibiotic regimens but resistance is a problem, with high rates of resistance to clarithromycin, metronidazole, and levofloxacin seen in Bangladesh. Management of peptic ulcers involves testing and treating H. pylori, endoscopic treatment for bleeding ulcers, and maintenance therapy to prevent
Chronic viral hepatitis can be caused by hepatitis B virus (HBV), hepatitis C virus (HCV), or hepatitis D virus (HDV). HBV is responsible for 60-80% of hepatocellular carcinoma worldwide. HCV infection is the most common chronic blood-borne infection and a leading cause of cirrhosis and liver cancer. HDV requires HBV coinfection and can cause a more severe form of hepatitis. Treatment for chronic HBV and HCV infection involves antiviral medications like interferons, nucleoside analogs, and nucleotide analogs to achieve viral suppression and prevent disease progression.
Management of Typhoid Intestinal Perforation which is a common and the most dreaded surgical complication of Typhoid fever.
This menace is still on the rise in low and medium income countries where we still battle with lack of potable water and open defecation.
This presentation is especially targeted at trainee surgeons in Nigeria and Medical Students also who may find it worthwhile.
This organism, formerly known as Campylobacter pylori, is now known as Helicobacter pylori, a curved bacterium that colonizes the gastric mucosa. H. pylori has been found in 90% of patients with chronic gastritis, 95% with duodenal ulcer disease, and 70% with gastric ulcer. Chronic gastritis is defined as the presence of chronic inflammatory changes in the mucosa leading to mucosal atrophy and epithelial metaplasia. The two main causes of chronic gastritis are infection by H. pylori and autoimmune gastritis. Left untreated, chronic gastritis increases the risk of peptic ulcer disease and gastric adenocarc
Helicobacter pylori is a spiral-shaped bacteria that lives in the stomach. It was originally considered that bacteria could not survive in the acidic stomach. Marshall and Warren first cultured H. pylori from human stomachs and showed it was associated with gastric inflammation. H. pylori infection can cause dyspepsia, peptic ulcers, gastric cancer, and other diseases. Testing and treating H. pylori infections can help prevent future illness.
The gallbladder is a hollow organ located beneath the liver that stores and concentrates bile. Cholecystitis is inflammation of the gallbladder, usually caused by gallstones blocking the cystic duct. Symptoms include pain in the upper right abdomen and fever. Ultrasound is often used to diagnose cholecystitis by detecting gallstones or thickening of the gallbladder wall. Treatment typically involves surgical removal of the gallbladder via laparoscopy.
Chronic hepatitis is defined as ongoing liver inflammation lasting over 6 months. It is commonly caused by hepatitis B, C, or a combination. Clinical features include fatigue, loss of appetite, jaundice, and elevated liver enzymes. On microscopy, chronic hepatitis shows piecemeal necrosis around the portal tract, interface hepatitis between liver lobes, and bridging fibrosis linking different areas. The activity of chronic hepatitis is assessed based on necrosis, inflammation, and fibrosis levels, and used to classify it as persistent, lobular, or active hepatitis. Carriers have no symptoms but can transmit hepatitis viruses through detectable surface antigens in their blood.
Helicobacter pylori is a spiral-shaped bacterium that can cause peptic ulcer disease and is associated with gastric cancer. It colonizes the stomach and causes a chronic inflammatory response. Several bacterial virulence factors like the cag pathogenicity island, vacuolating cytotoxin, and urease contribute to pathogenesis. H. pylori infection typically results in chronic gastritis and in some cases can lead to more severe outcomes like peptic ulcers, gastric atrophy, intestinal metaplasia, and cancer. Diagnosis involves endoscopy with biopsy to detect the bacteria through histology or other tests. Treatment aims to eradicate the infection through antibiotic therapy combined with proton pump inhibitors.
To know basic etiology of this disease and difference between duodenal ulcer and peptic ulcer as well as how we can approach if children having peptic ulcer disease. By conservative and surgical means
Laboratory diagnosis of H. Pylori infection, Ola ElgaddarOla Elgaddar
A short presentation for the different laboratory techniques used in diagnosing Helicobacter Pylori infection. A special focus is given for the diagnostic performance of every test.
This document provides information about Helicobacter pylori (H. pylori), including how it is transmitted, symptoms it causes, specimens used to test for it, and methods for diagnosing and confirming infection. H. pylori is a bacteria that infects the stomach and is associated with gastric ulcers and cancer. It is transmitted orally-orally or orally-fecal. Common symptoms include abdominal pain and weight loss. Diagnosis can be made through serology tests of whole blood, serum, stool or breath samples, or biopsy during endoscopy. Serology tests detect antibodies but cannot confirm active infection. Stool and breath tests can diagnose active infection and confirm cure. Biopsy during endoscopy
This document discusses Zollinger-Ellison syndrome, which is characterized by severe peptic ulcers caused by excessive stomach acid production due to a non-beta cell tumor known as a gastrinoma. It describes the pathophysiology, tumor distribution, clinical manifestations, diagnosis, and treatment of the condition. The gastrinoma secretes gastrin which stimulates acid secretion, potentially reaching the small intestine and inactivating pancreatic enzymes. Diagnosis involves biochemical tests and imaging to locate the tumor. Treatment options include proton pump inhibitors, somatostatin analogues, and surgery to cure the condition.
Inflammatory Bowel Disease (IBD) refers to two conditions: Crohn's disease and ulcerative colitis. Crohn's disease causes chronic inflammation of the gastrointestinal tract that can affect any location from mouth to anus in a discontinuous pattern. Ulcerative colitis causes non-granulomatous inflammation of the colon and rectum in a continuous pattern beginning in the rectum. The causes of IBD are not fully known but involve an immune reaction to environmental triggers in genetically predisposed individuals. Symptoms vary depending on the location and severity of inflammation. Management involves non-pharmacological approaches as well as medications to reduce inflammation like aminosalicates, corticosteroids, immunosuppress
Chronic gastritis is a chronic inflammation of the gastric mucosa that commonly results from infection by Helicobacter pylori in 90% of cases. Other causes include NSAID use, smoking, stress, and ischemia. H. pylori infection leads to increased acid secretion and damage to the gastric epithelium. Chronic gastritis is classified based on location and cause, and is usually asymptomatic, though pain, dyspepsia, and fatigue may occur. Diagnosis involves endoscopy, biopsy, and urease testing. Treatment focuses on H. pylori eradication therapy using antibiotic combinations for 10-14 days along with diet and lifestyle modifications. Complications include ulcers, gastric cancer, and
Peptic ulcer disease is caused by gastric or duodenal ulcers that form lesions in the stomach or duodenal mucosa. Risk factors include H. pylori infection, smoking, NSAID use, and genetic factors. Symptoms include epigastric pain relieved by food and antacids. Treatment aims to relieve pain, eradicate H. pylori infection, heal ulcers, and prevent recurrence through lifestyle changes and medication like PPIs or H2 blockers. Surgery was more common historically but is now rare due to H. pylori treatments, though it may be used for complications like perforation.
Chronic gastritis is long-term inflammation of the stomach lining that can be caused by factors like H. pylori infection, medications, alcohol, or diet. It is classified based on etiology (cause), morphology (appearance), and location in the stomach. The OLGA staging system scores and stages gastritis severity based on the degree of atrophy in the antrum and corpus as seen histologically. Treatment involves eliminating the cause, such as treating an H. pylori infection, and managing symptoms.
This document provides an overview of irritable bowel syndrome (IBS), including its definition, prevalence, demographics, pathophysiology, clinical features, diagnosis, differential diagnosis, severity assessment, management, and prognosis. Some key points are:
- IBS is a functional bowel disorder characterized by abdominal pain associated with changes in bowel habits. It predominantly affects those aged 15-65 and is more common in women.
- The pathophysiology involves altered gut motility, visceral hypersensitivity, abnormal gas handling, low-grade inflammation, food sensitivities, abnormal gut microbiota, and central nervous system dysregulation.
- Diagnosis is based on symptoms meeting certain criteria and exclusion of organic diseases. Management focuses on
Peptic ulcer disease is caused by Helicobacter pylori (Hp) infection and nonsteroidal anti-inflammatory drug (NSAID) use. Definitive diagnosis is by endoscopy, which can detect ulcers and test for Hp. Common complications are bleeding, perforation, and pyloric obstruction. Treatment involves eradicating Hp, relieving symptoms with anti-ulcer drugs, and preventing recurrence with long-term proton pump inhibitor use.
This document discusses gastroesophageal reflux disease (GERD). It begins by defining GERD as a condition caused by stomach contents refluxing into the esophagus and causing troublesome symptoms or complications. It then discusses the pathophysiology of GERD, noting that the lower esophageal sphincter normally acts as a barrier but can become disrupted, allowing acid to reflux from the stomach into the esophagus. The document outlines the clinical manifestations of GERD including heartburn, regurgitation, and extraesophageal symptoms. It also discusses diagnostic evaluations for GERD including endoscopy, pH monitoring, and manometry. The document concludes by covering treatment options for GERD including lifestyle modifications
The document discusses biliary dyskinesia, a disorder where the gallbladder does not contract and empty properly, causing digestive issues. It describes the anatomy and role of the biliary system, signs and symptoms of biliary dyskinesia including abdominal pain and nausea, potential causes, diagnostic tests and treatments including diet changes and medication. Nutritional guidelines recommend a low-fat diet, fiber, staying hydrated, supplements, weight management and probiotics to support gallbladder function and digestion.
This document provides an overview of amoebiasis (Entamoeba histolytica infection). It discusses the definition, life cycle, epidemiology, pathogenesis, clinical manifestations, diagnosis and treatment of intestinal amoebiasis as well as extra-intestinal infections such as amoebic liver abscess. Key points include that 90% of E. histolytica infections are asymptomatic but 10% can cause intestinal or extraintestinal disease ranging from dysentery to liver abscesses. Diagnosis involves microscopy of stool, biopsy or abscess aspirate samples. Treatment depends on the clinical presentation and involves metronidazole and other drugs.
Helicobacter pylori associated Peptic ulcer diseaseS M Ali Hasan
Helicobacter pylori is a common cause of peptic ulcer disease. It infects about half of the global population and transmission occurs through person-to-person contact or from infected instruments. Only 10-15% of infected individuals develop ulcers or other diseases. In Bangladesh, H. pylori infection rates are very high, ranging from 67-92% in studies. Treatment involves antibiotic regimens but resistance is a problem, with high rates of resistance to clarithromycin, metronidazole, and levofloxacin seen in Bangladesh. Management of peptic ulcers involves testing and treating H. pylori, endoscopic treatment for bleeding ulcers, and maintenance therapy to prevent
Chronic viral hepatitis can be caused by hepatitis B virus (HBV), hepatitis C virus (HCV), or hepatitis D virus (HDV). HBV is responsible for 60-80% of hepatocellular carcinoma worldwide. HCV infection is the most common chronic blood-borne infection and a leading cause of cirrhosis and liver cancer. HDV requires HBV coinfection and can cause a more severe form of hepatitis. Treatment for chronic HBV and HCV infection involves antiviral medications like interferons, nucleoside analogs, and nucleotide analogs to achieve viral suppression and prevent disease progression.
Management of Typhoid Intestinal Perforation which is a common and the most dreaded surgical complication of Typhoid fever.
This menace is still on the rise in low and medium income countries where we still battle with lack of potable water and open defecation.
This presentation is especially targeted at trainee surgeons in Nigeria and Medical Students also who may find it worthwhile.
This organism, formerly known as Campylobacter pylori, is now known as Helicobacter pylori, a curved bacterium that colonizes the gastric mucosa. H. pylori has been found in 90% of patients with chronic gastritis, 95% with duodenal ulcer disease, and 70% with gastric ulcer. Chronic gastritis is defined as the presence of chronic inflammatory changes in the mucosa leading to mucosal atrophy and epithelial metaplasia. The two main causes of chronic gastritis are infection by H. pylori and autoimmune gastritis. Left untreated, chronic gastritis increases the risk of peptic ulcer disease and gastric adenocarc
Helicobacter pylori is a gram-negative, spiral-shaped bacterium that infects the stomachs of approximately half of the world's population. It is the primary cause of peptic ulcers and is associated with chronic gastritis and gastric cancer. In Pakistan, a study found the prevalence of H. pylori infection to be 74.4%, with risk factors including presence of household animals and larger family size. H. pylori infection is usually treated with a combination of proton pump inhibitors, antibiotics, and bismuth to achieve eradication rates as high as 93%.
C:\Documents And Settings\Louay Labban Uok\Desktop\All\Powerpoints\Helicopact...Prof.Louay Labban
This document discusses Helicobacter pylori, a common bacterium found in the stomach that can cause various gastrointestinal issues. It is present in about half of the world's population. While most infected individuals do not experience symptoms, H. pylori is linked to ulcers, gastritis, and in rare cases, stomach cancer. The document outlines risk factors for infection, potential symptoms, diagnostic tests including blood tests and breath tests, and recommendations for who should be tested.
C:\Documents And Settings\Louay Labban Uok\Desktop\All\Powerpoints\Helicopact...Prof.Louay Labban
This document discusses Helicobacter pylori, a common bacterium found in the stomach that can cause various gastrointestinal issues. It is present in about half of the world's population. While most infected individuals do not experience symptoms, H. pylori is linked to ulcers, gastritis, and in rare cases, stomach cancer. The document outlines risk factors for infection, potential symptoms, diagnostic tests including blood tests and breath tests, and recommendations for who should be tested.
C:\Documents And Settings\Louay Labban Uok\Desktop\All\Powerpoints\Helicopact...Prof.Louay Labban
This document discusses Helicobacter pylori, a common bacterium found in the stomach that can cause various gastrointestinal issues. It is present in about half of the world's population. While most infected individuals do not experience symptoms, H. pylori is linked to ulcers, gastritis, and in rare cases, stomach cancer. The document outlines risk factors for infection, potential symptoms, diagnostic tests including blood tests and breath tests, and recommendations for who should be tested.
The document discusses Campylobacter and Helicobacter bacteria, including how Campylobacter can cause food poisoning and Guillain-Barré syndrome, and how Helicobacter pylori was discovered to be a cause of peptic ulcers and gastritis. It provides details on the characteristics, diagnosis, treatment, and prevalence of H. pylori infections, and notes that Robin Warren and Barry Marshall received the Nobel Prize for their research showing H. pylori's role in peptic ulcer disease.
This document discusses peptic ulcer disease, including its causes, symptoms, diagnosis and treatment. The predominant causes are Helicobacter pylori (H. pylori) infection and NSAID use. H. pylori infection is associated with 50-75% of ulcers in developed countries. Diagnosis involves invasive tests like endoscopy or noninvasive tests like the urea breath test. Treatment involves eradicating H. pylori, reducing acid levels with PPIs or H2 blockers, and lifestyle changes like quitting smoking.
H. pylori is a gram-negative, microaerophilic bacterium that colonizes the stomach and is associated with gastritis, peptic ulcers, and gastric cancer. It is spiral-shaped with multiple sheathed flagella that enable movement. H. pylori infection is transmitted orally and causes inflammation and damage to the gastric mucosa through virulence factors like urease and cytotoxin. Diagnosis involves invasive tests on gastric biopsy or non-invasive breath, stool, and blood tests. Eradication of H. pylori can cure peptic ulcers.
CHRONIC DYSPEPSIA
Seminar Prepared by :-
Ali Abdulazeem
Shilan Adnan Abdulrahman
Alaa Shamil
Guldan Hameed
Internal Medicine
College of Medicine - University of Kirkuk
Aetiopathophysiology of peptic ulcer diesesePrince Lathiya
1. Peptic ulcers are erosions in the gastric or duodenal mucosa that are caused by an imbalance between defensive and damaging factors like H. pylori infection, NSAIDs, and smoking.
2. H. pylori infection and NSAID use are the most common causes of peptic ulcers, as they compromise the mucosal defense system through various mechanisms like toxin production, inflammation, and decreased prostaglandin levels.
3. Duodenal ulcers are more common than gastric ulcers and are often associated with increased acid secretion, while gastric ulcers can form with normal acid levels due to damage to the mucus barrier.
Dr. T.V. Rao provides an overview of Helicobacter pylori (H. pylori), the bacterium associated with peptic ulcer disease and gastric cancer. Some key points:
- H. pylori was discovered in 1983 by Warren and Marshall and linked to gastritis and ulcers. They received the 2005 Nobel Prize in Physiology or Medicine.
- H. pylori colonizes the stomach of about half of individuals worldwide. It is a gram-negative, spiral-shaped bacterium that lives in the mucus layer of the stomach.
- H. pylori infection can cause chronic gastritis, peptic ulcers, and in rare
The document discusses Campylobacter and Helicobacter bacteria, including how Campylobacter can cause food poisoning and Guillain-Barré syndrome, and how Helicobacter pylori was discovered in the stomach and linked to peptic ulcers. It provides details on the diagnosis and treatment of H. pylori infections, noting that a combination of antibiotics along with bismuth is the most effective treatment approach.
This document discusses peptic ulcers, including their causes, symptoms, diagnosis, and treatment. Peptic ulcers are abnormalities in the gastrointestinal tract caused by damage from stomach acid. The most common causes are infection with Helicobacter pylori bacteria and long-term use of nonsteroidal anti-inflammatory drugs. Common symptoms include abdominal pain, nausea, and vomiting of blood. Diagnosis involves tests to detect H. pylori infection and endoscopy to view the ulcers. Treatment focuses on eradicating H. pylori with antibiotics, reducing stomach acid with proton pump inhibitors or H2 blockers, and protecting the lining with sucralfate.
Peptic ulcer disease is defined as a discontinuity in the gastric or duodenal mucosa exposed to acid and pepsin secretion. Common causes include H. pylori infection, NSAID use, and stress. H. pylori infection is associated with 95% of duodenal ulcers and 80% of gastric ulcers. NSAID use inhibits prostaglandins, which protect the gastric mucosa. Treatment involves antibiotics to eradicate H. pylori, PPIs to reduce acid secretion, and medications to protect the gastric lining such as sucralfate. Triple therapy with a PPI and two antibiotics is the standard treatment to eradicate H. pylori.
Peptic ulcer disease causes and treatmentAbu Bakar
Peptic ulcer disease is defined as a discontinuity in the gastric or duodenal mucosa exposed to acid and pepsin secretion. Common causes include H. pylori infection, NSAID use, and stress. H. pylori infection is associated with 95% of duodenal ulcers and 80% of gastric ulcers. NSAID use inhibits prostaglandins, which protect the gastric mucosa. Treatment involves antibiotics to eradicate H. pylori, PPIs to reduce acid secretion, and medications to protect the gastric lining such as sucralfate. Triple therapy with a PPI and two antibiotics is the standard treatment to eradicate H. pylori.
Helicobacter pylori is a gram-negative bacterium that infects the human gastrointestinal tract and is the primary cause of peptic ulcers and chronic gastritis. It is transmitted via the fecal-oral route and the human GI tract is its only reservoir. Diagnosis is usually made via non-invasive breath, blood, or stool tests but endoscopy with biopsy is most accurate. H. pylori infections are treated with combinations of antibiotics and proton pump inhibitors to reduce acid and help the stomach heal. Left untreated, H. pylori infection increases the risk of peptic ulcers, gastric cancer, and other diseases.
The document discusses the history and discovery of Helicobacter pylori and its role in peptic ulcer disease. It describes how in the 1980s, Drs. Barry Marshall and Robin Warren discovered that H. pylori infection was a major cause of peptic ulcers, overturning decades of belief. Their discovery was initially met with resistance from the medical community but was later recognized with the 2005 Nobel Prize in Physiology or Medicine. The document also discusses the epidemiology, diagnosis, treatment and antibiotic resistance of H. pylori infection.
A 50-year-old farmer from Gujranwala presented with abdominal pain, jaundice, and urticaria. Differential diagnoses include liver abscess and hydatid disease. Investigations would include blood tests, imaging like ultrasound and CT, and fluid aspiration/culture. Initial management depends on diagnosis but may include antibiotics, drainage, or anti-parasitic drugs. Liver abscesses are generally pyogenic, amoebic, or fungal in origin and present variably. Hydatid disease involves cyst formation from Echinococcus tapeworms and usually affects the liver. Treatment involves surgery, percutaneous drainage, or anti-parasitic drugs depending on individual factors.
Helicobacter pylori is a gram-negative, microaerophilic bacterium that colonizes the stomach and causes chronic gastritis. It is the primary cause of peptic ulcer disease and is associated with an increased risk of gastric cancer. H. pylori is transmitted via the fecal-oral route and the human gastrointestinal tract is its only known reservoir. Diagnosis is typically made through non-invasive testing like a urea breath test or endoscopy with biopsy and testing. Common diseases associated with H. pylori include chronic gastritis, duodenal and gastric ulcers, and gastric carcinoma. Treatment involves a combination of antibiotics like amoxicillin and metronidazole along
Training HCWs for infection Control.pptxPradeep Pande
This document outlines various infection control and prevention measures for healthcare workers during the COVID-19 pandemic. It discusses proper hand hygiene techniques, use of personal protective equipment like masks and gloves, safe handling of sharps, cleaning and disinfection of surfaces and medical equipment, respiratory hygiene, waste management, and isolation precautions. The key principles are frequent hand washing, avoiding touching the face, social distancing, proper use and disposal of PPE, thorough cleaning and disinfection of facilities, and protecting healthcare workers during high-risk procedures through appropriate PPE and protocols.
The document provides tips for using a PowerPoint presentation (PPT) for teaching. It suggests displaying blank slides to elicit student responses before presenting content. Showing blank slides, asking questions, then displaying answers promotes active learning. The PPT can also be used for self-study by viewing blank slides and thinking of answers before reading the next slide. The rest of the document describes learning objectives and an outline for a session on benign tumors of the small intestine.
Mesenteric ischemia is a life-threatening condition caused by inadequate blood flow to the intestines. It can be caused by embolism, arterial thrombosis, non-occlusive disease, or venous thrombosis. Patients experience severe, disproportionate abdominal pain and may develop peritonitis, sepsis, or hematochezia. Diagnosis involves CT angiography. Treatment focuses on restoring blood flow via techniques like thrombolysis, angioplasty, or surgery to remove infarcted bowel. Mortality rates are high but can be reduced with early diagnosis and intervention.
The document discusses multiple choice questions about small bowel tumors. It states that small bowel tumors are commonly located in the duodenum, lymphoma is a common type of small bowel tumor, and palliative surgeries are performed even in the presence of metastasis.
Small bowel carcinoids most commonly occur in the duodenum. They do not cause endocardial fibroelastosis but can increase the risk of lung cancer. Small bowel carcinoids are also the most common tumor found in the small intestine. Duodenal adenocarcinoma is the most common type of small bowel carcinoma. Jaundice and anemia are the most common symptoms, and local resection can potentially provide a cure.
An elderly male with a history of ischemic heart disease and cerebrovascular disease presented with abdominal pain and bloody stools. The likely diagnosis is acute mesenteric ischemia given his risk factors and symptoms. Acute mesenteric ischemia is most commonly caused by arterial thrombosis. A patient with similar symptoms and risk factors was diagnosed with acute mesenteric ischemia based on their abdominal pain, tenderness, distension, absent bowel sounds, and maroon colored stool.
The document discusses mesenteric venous thrombosis and its treatment. Intravenous heparin is the treatment of choice for mesenteric venous thrombosis. While peritoneal signs are not always present, surgery for mesenteric venous thrombosis can lead to short bowel syndrome.
The document discusses potential causes of strangulating hernia and strangulated intestinal obstruction. It lists volvulus, mesenteric vascular occlusion, intussusception, and gallstone ulcers as potential causes of strangulating hernia, with gallstone ulcers being identified as the exception. For strangulated intestinal obstruction, intussusception is identified as not being a potential cause, with mesenteric vascular occlusion, gall stone ileus, and volvulus listed as potential causes.
This document discusses chronic mesenteric ischemia and its symptoms. It states that normal barium studies is not typically seen with chronic mesenteric ischemia. It also asks what is the most common cause of mesenteric ischemia, with the answer being arterial thrombosis.
A three-year-old male child presented with constipation and abdominal distension for two years. Imaging showed dilated bowel loops containing feces. Barium enema revealed a transition zone at the rectosigmoid junction with reversal of the normal ratio, consistent with Hirschsprung's disease. Hirschsprung's disease involves absence of ganglion cells in the intestinal wall, causing a contracted nonperistaltic segment above a dilated segment of normal colon. Rectal biopsy is the diagnostic investigation of choice to identify the absence of ganglion cells.
The document contains multiple choice questions (MCQs) about a person who had undergone gastrojejunostomy or gastrojejunotomy surgery and suddenly developed severe diarrhea. For each MCQ, the possible answers are various gastrointestinal conditions including gastric carcinoma, TB abdomen, gastrojejunocolic fistula, and gastric amoebiasis. The last question asks about the best diagnostic test for picking up a gastrojejunocolic fistula.
The document discusses the most common cause of death in patients with gastrointestinal fistulas. It presents four options - electrolyte imbalance, severe dehydration, malnutrition, and sepsis. The correct answer is that sepsis is the most common cause of death in patients with gastrointestinal fistulas.
The document contains multiple choice questions (MCQs) about gastrocolic fistulas and associated conditions:
1) Diarrhea in gastrocolic fistula is due to peptic digestion of the colonic mucosa by gastric contents passing through the fistula.
2) Gastrocolic fistulas usually follow near total gastrectomy surgical procedures.
3) Rectal polyposis is not associated with metabolic acidosis unlike the other conditions listed which include gastrocolic fistula and prolonged diarrhea.
Thyroid Anatomy, Pysiology, Development MCQ.pptxPradeep Pande
The document contains a series of multiple choice questions about the thyroid gland. It asks which layer of cervical fascia encloses the thyroid, what manifestation would be seen if sympathetic nerves to the thyroid are damaged during surgery, which condition is marked by low thyroid stimulating hormone levels, and which gland regulates and controls the activity of the thyroid. The answers provided are the superficial cervical fascia, vocal cord paralysis, hyperthyroidism, and both the pituitary gland and hypothalamus, respectively.
The document contains a series of multiple choice questions related to splenic rupture. Specifically:
- Kehr's sign, which is pain in the left shoulder, indicates splenic rupture.
- A patient presenting with abdominal trauma, a fractured rib, and bruising over the left hypochondrium most likely has a splenic rupture.
- Cirrhosis of the liver is the exception among conditions that can cause spontaneous rupture of the spleen.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Nano-gold for Cancer Therapy chemistry investigatory projectSIVAVINAYAKPK
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
How to Control Your Asthma Tips by gokuldas hospital.Gokuldas Hospital
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Know the difference between Endodontics and Orthodontics.Gokuldas Hospital
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
Know the difference between Endodontics and Orthodontics.
H.Pylori and peptic ulcer.pptx
1. Tips on using my ppt.
1. You can freely download, edit, modify and put your
name etc.
2. Don’t be concerned about number of slides. Half the
slides are blanks except for the title.
3. First show the blank slides (eg. Aetiology ) > Ask
students what they already know about ethology of
today's topic. > Then show next slide which enumerates
aetiologies.
4. At the end rerun the show – show blank> ask questions >
show next slide.
5. This will be an ACTIVE LEARNING SESSION x
three revisions.
6. Good for self study also.
7. See notes for bibliography.
5. Introduction & History.
• Peptic ulcer disease is thought to be a lifestyle
disease caused by “hurry, worry and curry.
• It has been known for more than a century that
bacteria are present in the human stomach.
• These bacteria, however, were thought to be
contaminants from digested food rather than true
gastric colonizers.
• Persistence of a pathogen in an environment long
thought to be sterile is not likely.
6. Introduction & History.
• Robin Warren and Barry Marshall thought
and later proved that H. pylori is
pathogenic.
• This discovery resulted in the awarding of
the 2005 Nobel Prize in Physiology or
Medicine to Robin Warren and Barry
Marshall for their “discovery of the
bacterium Helicobacter pylori and its role
in gastritis and peptic ulcer disease.”
8. Relevant Microbiology
• H. pylori is a gram-negative bacterium,
measuring 2 to 4 μm in length and 0.5 to 1
μm in width.
• spiral-shaped,
• It has 2 to 6 unipolar, sheathed flagella
• Microaerophilic.
• It has 2 to 6 unipolar, sheathed flagella
• Urease positive. Those organisms that are
capable of hydrolyzing urea to produce
ammonia and carbon dioxide.
9. Relevant Microbiology
• Urease is thought to allow short-term
survival in the highly acidic gastric lumen,
whereas motility is thought to allow rapid
movement toward the more neutral pH of
the gastric mucosa; this may explain why
both factors are prerequisites for
colonization of the gastric mucosa.
13. Pathology
• Colonization with H. pylori virtually always leads
to infiltration of the gastric mucosa in both antrum
and corpus with neutrophilic and mononuclear
cells
• This Chronic Active Gastritis is the primary
condition related to H. pylori colonization, and
other H. pylori-associated disorders in particular
result from this chronic inflammatory process.
14. Pathology
• Atrophic gastritis, intestinal metaplasia, and
gastric cancer.
• Chronic H. pylori-induced inflammation can
eventually lead to loss of the normal gastric
mucosal architecture, with destruction of gastric
glands and replacement by fibrosis and intestinal-
type epithelium.
• This process of atrophic gastritis and intestinal
metaplasia occurs in approximately half of the H.
pylori-colonized population,
• they increase the risk for gastric cancer by 5- to
90-fold depending on the extent and severity of
atrophy
15. Peptic ulcer disease
• Gastric or duodenal ulcers (commonly
referred to as peptic ulcers) are defined as
mucosal defects with a diameter of at least
0.5 cm penetrating through the muscularis
mucosa
• Gastric ulcers mostly occur along the lesser
curvature of the stomach, in particular, at
the transition from corpus to antrum mucosa
• Duodenal ulcers usually occur in the
duodenal bulb, which is the area most
exposed to gastric acid.
16. Peptic ulcer disease
• Duodenal ulcers are approximately fourfold
more common than gastric ulcers;
Duodenal ulcers in particular occur between
20 and 50 years of age, while gastric ulcers
predominantly arise in subjects over 40
years old.
17. Association with H. pylori.
• Both gastric and duodenal ulcer diseases are
strongly related to H. pylori.
• Approximately 95% of duodenal ulcers and
85% of gastric ulcers occurred in the
presence of H. Pylori infection
• Eradication of this bacterium strongly
reduced the risk of recurrent ulcer disease
• This has had a major impact on the
treatment and course of peptic ulcer disease
in daily clinical practice.
18. Association with H. pylori.
• In earlier days, this disease was a chronic,
recurrent disorder with high morbidity,
frequently requiring acid-suppressive
maintenance therapy or surgery.
• Approximately 50% of patients with H.
pylori-associated peptic ulcer disease
suffered ulcer recurrence within 1 year
• Eradication of H. pylori dramatically
changes the natural course of ulcer disease
and almost completely prevents ulcer
recurrence.
20. Demography
• H. pylori infection rates rise rapidly in the
first 5 years of life and remain constantly
high thereafter, indicating that H. pylori is
acquired early in childhood.
• Infection more commonly occurs in
childhood and lasts for life unless
specifically treated.
21. Transmission and Sources of Infection
• The exact mechanisms whereby H. Pylori is
acquired are largely unknown.
• It is found almost exclusively in humans
and some nonhuman primates.
• Rare occasions been isolated from pet
animals;
• Direct human-to-human transmission, via
either an oral-oral or fecal-oral route or
both.
• ?Contaminated food,
22. CLINICAL ASPECTS OF H. PYLORI-
ASSOCIATED DISEASES
• Colonization with H. pylori is not a disease
in itself but a condition that affects the
relative risk of developing various clinical
disorders of the upper gastrointestinal tract
and possibly the hepatobiliary tract.
• Testing for H. pylori therefore has no
relevance by itself but should be performed
to find the cause of an underlying condition,
such as peptic ulcer disease, or for the
purpose of disease prevention, such as in
subjects with familial gastric cancer
24. Prognosis
• Although gastric colonization with H.
pylori induces histologic gastritis in all
infected individuals, only a minority
develop any apparent clinical signs of this
colonization.
• H. pylori-positive patients have a 10 to
20% lifetime risk of developing ulcer
disease
• 1 to 2% risk of developing distal gastric
cancer.
31. Investigations
• Endoscopic or invasive
1. Rapid urease test
2. Histopathology
3. Culture.
• Rapid urease tests are considered the
endoscopic diagnostic test of choice.
32. Investigations
• Urea breath tests detect active H
pylori infection by testing for the enzymatic
activity of bacterial urease. In the presence
of urease produced by H pylori, labeled
carbon dioxide (heavy isotope, carbon-13,
or radioactive isotope, carbon-14) is
produced in the stomach, absorbed into the
bloodstream, diffused into the lungs, and
exhaled.
33. Investigations
• Obtain histopathology, often considered the
criterion standard to establish a diagnosis
of H pylori infection, if the rapid urease test
result is negative and a high suspicion for H
pylori persists (presence of a duodenal
ulcer).
36. Treatment
• Proton pump inhibitor (ppi)–based triple
and 4drug therapy.
• Two antibiotics with a ppi.
• Tetracycline
• Amoxicillin
• Imidazoles (predominantly metronidazole
and tinidazole)
• Few selected macrolides (in particular
clarithromycin, sometimes azithromycin)
• Bismuth
38. Futuristic
• Preventive vaccination
• Enteric helminth infection can modulate the
host's immune system to attenuate H.
Pylori-induced gastric ulceration, atrophy,
and cancer
• Probiotics prevent infection with pathogenic
bacteria both through activation of the host's
immune system and through direct
competition of the probiotic bacteria with
the pathogen.
39. Futuristic
• Nowadays, even barry marshall sees the
germ’ two faces – the dangerous and the
helpful.
• Skin allergies or hay fever
• The bacteria also seem to provide a certain
protection against coeliac conditions, also
known as wheat gluten intolerance.
• Connection between its eradication and the
growing obesity problem worldwide.
40. Get this ppt in mobile
1. Download Microsoft
PowerPoint from play
store.
2. Open Google assistant
3. Open Google lens.
4. Scan qr code from
next slide.
41.
42. Get this ppt in mobile
1. Download Microsoft
PowerPoint from play
store.
2. Open Google assistant
3. Open Google lens.
4. Scan qr code from
next slide.
Various tests have been developed for the detection of H. pylori, each with their specific advantages and disadvantages (Table (Table2).2). The available tests are generally divided into invasive tests, based on gastric specimens for histology, culture, or other methods, and noninvasive tests, based on peripheral samples, such as blood, breath samples, stools, urine, or saliva for detection of antibodies, bacterial antigens, or urease activity. The choice of a specific test for an individual patient depends on local experience and the clinical setting (for reviews, see references 372, 640, and 713). In research protocols, a combination of two methods is often applied. In daily clinical practice, use of a single test is generally adequate, and most tests are sufficiently accurate to be used for this purpose. For routine diagnostic purposes, histology, urea breath testing, and culture are currently most often used, whereas the use of serology is most appropriate for large epidemiological studies (Table (Table2).2). In hospital-based care, many patients undergo endoscopy, which is then combined with an invasive test for H. pylori. Otherwise, breath tests and serology are commonly used. For children, fecal antigen tests offer the opportunity to assess H. pylori status without the need for endoscopy or vena puncture
Various tests have been developed for the detection of H. pylori, each with their specific advantages and disadvantages (Table (Table2).2). The available tests are generally divided into invasive tests, based on gastric specimens for histology, culture, or other methods, and noninvasive tests, based on peripheral samples, such as blood, breath samples, stools, urine, or saliva for detection of antibodies, bacterial antigens, or urease activity. The choice of a specific test for an individual patient depends on local experience and the clinical setting (for reviews, see references 372, 640, and 713). In research protocols, a combination of two methods is often applied. In daily clinical practice, use of a single test is generally adequate, and most tests are sufficiently accurate to be used for this purpose. For routine diagnostic purposes, histology, urea breath testing, and culture are currently most often used, whereas the use of serology is most appropriate for large epidemiological studies (Table (Table2).2). In hospital-based care, many patients undergo endoscopy, which is then combined with an invasive test for H. pylori. Otherwise, breath tests and serology are commonly used. For children, fecal antigen tests offer the opportunity to assess H. pylori status without the need for endoscopy or vena puncture